Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Constipation? 2,098 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,098 reports of Constipation have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 5.3% of all adverse event reports for CABOZANTINIB S-MALATE.

2,098
Reports of Constipation with CABOZANTINIB S-MALATE
5.3%
of all CABOZANTINIB S-MALATE reports
91
Deaths
359
Hospitalizations

How Dangerous Is Constipation From CABOZANTINIB S-MALATE?

Of the 2,098 reports, 91 (4.3%) resulted in death, 359 (17.1%) required hospitalization, and 9 (0.4%) were considered life-threatening.

Is Constipation Listed in the Official Label?

Yes, Constipation is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Constipation?

LENALIDOMIDE (9,635) NIRAPARIB (4,128) ADALIMUMAB (4,063) SEMAGLUTIDE (4,036) TIRZEPATIDE (3,417) ERENUMAB-AOOE (3,104) MORPHINE (2,979) OXYCODONE (2,747) PALBOCICLIB (2,705) POMALIDOMIDE (2,374)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Constipation Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Constipation Reports All Drugs Causing Constipation CABOZANTINIB S-MALATE Demographics